Profil
Antoine Yver currently serves as Independent Director at Sanofi since 2022, Director at Spotlight Therapeutics, Inc. since 2022, and Director at Stipple Bio, Inc. Former roles include Executive Vice President & Chairman-Development at Centessa Pharmaceuticals Plc from 2022 to 2024, Senior Director-Clinical Research at Aventis SA from 1990 to 2005, Executive Director-Oncology at Schering-Plough SAS from 2006 to 2009, Senior Director-Oncology at Johnson & Johnson Medical SAS from 2005 to 2006, Head-Global Medicines Development at AstraZeneca PLC from 2015 to 2016, and EVP, Global Head-Oncology Research and Development at Daiichi Sankyo Co., Ltd. from 2016 to 2021.
Education includes undergraduate and doctorate degrees from Université Paris-Saclay.
Aktive Positionen von Antoine Yver
| Unternehmen | Position | Beginn |
|---|---|---|
| SANOFI | Direktor/Vorstandsmitglied | 03.05.2022 |
One-Carbon Therapeutics AB
One-Carbon Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer therapeutics | Vorsitzender | - |
Stipple Bio Inc.
Stipple Bio Inc. BiotechnologyHealth Technology Operates as biotechnology company | Direktor/Vorstandsmitglied | - |
D3 Bio, Inc. | Direktor/Vorstandsmitglied | - |
TOAD Oncology SA | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Antoine Yver
| Unternehmen | Position | Ende |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 07.03.2022 |
| DAIICHI SANKYO COMPANY, LIMITED | Corporate Officer/Principal | 01.04.2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2016 |
Schering-Plough SAS
Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2009 |
| ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Antoine Yver
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Daiichi Sankyo Co., Ltd.
Daiichi Sankyo Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and sale of pharmaceutical products | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
Schering-Plough SAS
Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Spotlight Therapeutics, Inc.
Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops gene editing therapeutics | Health Technology |
Johnson & Johnson Medical SAS
Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris-Saclay
Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centessa Pharmaceuticals Plc
Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
D3 Bio, Inc. | |
Stipple Bio Inc.
Stipple Bio Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
One-Carbon Therapeutics AB
One-Carbon Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer therapeutics | Health Technology |
TOAD Oncology SA |
















